Metraipolis › archive › dc_a5e3405732fc
Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41514629
- DOI
- 10.3390/cancers18010120
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T07:52:23.142Z
- SHA-256 of the archived text
37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25- Stable URL of this page
https://metraipolis.com/documento/dc_a5e3405732fc
How to cite
Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629 — Europe PMC (en), https://europepmc.org/article/MED/41514629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5e3405732fc (Metraipolis archive dc_a5e3405732fc, sha256 37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25)
BibTeX
@misc{dca5e3405732fc,
title = {Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral… — Europe PMC PMID:41514629},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41514629},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5e3405732fc; sha256 37900089d22056a05cc9e7c151becbb7795f91e57a17c3133db30f442194df25},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514629. Agents can read the archived copy with the MCP tool read_document.